Skip to main content
. Author manuscript; available in PMC: 2016 Jan 15.
Published in final edited form as: Int J Cancer. 2014 Jun 19;136(2):425–434. doi: 10.1002/ijc.29005

Figure 1.

Figure 1

Serum pepsinogen I (PGI), PGI/II ratio and gastrin-17 levels in persons with different gastric histopathologies in the Zhuanghe Gastric Diseases Screening Program, China. (a) Serum PGI levels in persons with different histopathologies in the gastric body; (b) Serum PGI/II ratio in persons with different histopathologies in the gastric body; (c) Serum gastrin-17 levels in persons with different gastric histopathologies in the gastric body; (d) Serum PGI levels in persons with different histopathologies in the gastric antrum; (e) Serum PGI/II ratio in persons with different histopathologies in the gastric antrum; (f) Serum gastrin-17 levels in persons with different histopathologies in the gastric antrum. Abbreviations: NAG: non-atrophic gastritis; AG: atrophic gastritis.